Search Clinical Trials
585,889 trials
ID
Status
Phase
Title
Sponsor
NCT07601282
Development and Validation of a Risk Prediction Model for De Novo Stress Urinary Incontinence After Pelvic Floor Reconstruction SurgeryShanghai General Hospital, Shanghai Jiao Tong University School of MedicineRecruiting
NCT07601282Recruiting
—
Development and Validation of a Risk Prediction Model for De Novo Stress Urinary...Shanghai General Hospital...
NCT07604207
Multi-organ Imaging of Microvascular and Metabolic FunctionMassachusetts General HospitalNot Yet RecruitingEarly Phase 1
NCT07604207Not Yet Recruiting
Early Phase 1
Multi-organ Imaging of Microvascular and Metabolic FunctionMassachusetts General Hos...
NCT07601061
Simplifying Diet Tracking in a Digital Weight Loss InterventionStanford UniversityNot Yet RecruitingNot Applicable
NCT07601061Not Yet Recruiting
Not Applicable
Simplifying Diet Tracking in a Digital Weight Loss InterventionStanford University
NCT07601841
Light Therapy to Improve Sleep in TBI: Sleep-active Biomarkers and Glymphatic FunctionOregon Health and Science UniversityRecruitingNot Applicable
NCT07601841Recruiting
Not Applicable
Light Therapy to Improve Sleep in TBI: Sleep-active Biomarkers and Glymphatic Fu...Oregon Health and Science...
NCT07604324
A First-in-human Study to Investigate Single Doses of DCY636 in Healthy Volunteers and Multiple Doses in Participants With Moderate to Severe Atopic DermatitisNovartis PharmaceuticalsNot Yet RecruitingPhase 1
NCT07604324Not Yet Recruiting
Phase 1
A First-in-human Study to Investigate Single Doses of DCY636 in Healthy Voluntee...Novartis Pharmaceuticals
NCT07604909
A Phase II Randomized Trial of Serplulimab With Second-Line Chemo/Targeted Therapy for Early Relapse Colorectal Cancer After Adjuvant ChemotherapyFudan UniversityRecruitingPhase 2
NCT07604909Recruiting
Phase 2
A Phase II Randomized Trial of Serplulimab With Second-Line Chemo/Targeted Thera...Fudan University
NCT07601009
Validity and Reliability of a Mixed Reality-Based 6-Minute Walk TestSelcuk UniversityRecruiting
NCT07601009Recruiting
—
Validity and Reliability of a Mixed Reality-Based 6-Minute Walk TestSelcuk University
NCT07601997
Safety and Feasibility of Transcatheter Injectable Hydrogel in Acute STEMI Reperfusion Injury (REFINE Study)Myomed Technology (Shaoxing) Co., Ltd.Not Yet RecruitingNot Applicable
NCT07601997Not Yet Recruiting
Not Applicable
Safety and Feasibility of Transcatheter Injectable Hydrogel in Acute STEMI Reper...Myomed Technology (Shaoxi...
NCT07604922
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney DiseaseImecNot Yet RecruitingNot Applicable
NCT07604922Not Yet Recruiting
Not Applicable
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or...Imec
NCT07600775
A Clinical Trial of MK-8527 and Rifampin in Adult Participants With Latent Tuberculosis Infection (MK-8527-019)Merck Sharp & Dohme LLCNot Yet RecruitingPhase 1
NCT07600775Not Yet Recruiting
Phase 1
A Clinical Trial of MK-8527 and Rifampin in Adult Participants With Latent Tuber...Merck Sharp & Dohme LLC
NCT07604480
Remimazolam-Propofol Combination Sedation for Gastrointestinal Endoscopy: A Prospective Observational StudyUniversity of Medicine and Pharmacy "Victor Babes" TimisoaraCompleted
NCT07604480Completed
—
Remimazolam-Propofol Combination Sedation for Gastrointestinal Endoscopy: A Pros...University of Medicine an...
NCT07601126
Respiratory Pathogen Distribution During and After the COVID-19 PandemicHisar Intercontinental HospitalCompleted
NCT07601126Completed
—
Respiratory Pathogen Distribution During and After the COVID-19 PandemicHisar Intercontinental Ho...
NCT07603687
Brief Behavioral Intervention for Insomnia Among Adults With Sleep DisturbancesNational Taiwan University HospitalNot Yet RecruitingNot Applicable
NCT07603687Not Yet Recruiting
Not Applicable
Brief Behavioral Intervention for Insomnia Among Adults With Sleep DisturbancesNational Taiwan Universit...
NCT07601048
A Trial of HRS-7058 in Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who Have Failed Standard TreatmentShandong Suncadia Medicine Co., Ltd.Not Yet RecruitingPhase 3
NCT07601048Not Yet Recruiting
Phase 3
A Trial of HRS-7058 in Advanced or Metastatic Non-Small Cell Lung Cancer Patient...Shandong Suncadia Medicin...
NCT07603219
Nurse-Led Educational Intervention for Caregivers of ICU Patients (Nurses For Family - N4F)Medical University of GdanskNot Yet RecruitingNot Applicable
NCT07603219Not Yet Recruiting
Not Applicable
Nurse-Led Educational Intervention for Caregivers of ICU Patients (Nurses For Fa...Medical University of Gda...
NCT07602361
Genetic Markers Associated With Capsaicinoid Supplementation Effects in Overweight and ObesityUniversidad Autonoma de Baja CaliforniaActive Not RecruitingNot Applicable
NCT07602361Active Not Recruiting
Not Applicable
Genetic Markers Associated With Capsaicinoid Supplementation Effects in Overweig...Universidad Autonoma de B...
NCT07605195
Research on the Whole-Process Intelligent Diagnosis and Treatment of Digital Breast Tomosynthesis Based on Deep LearningYunnan Cancer HospitalNot Yet RecruitingNot Applicable
NCT07605195Not Yet Recruiting
Not Applicable
Research on the Whole-Process Intelligent Diagnosis and Treatment of Digital Bre...Yunnan Cancer Hospital
NCT07604155
Maxillary Sinus Augmentation Using CAD/CAM Allogenic Bone Blocks Versus Particulate Allogenic GraftsTanta UniversityEnrolling By InvitationNot Applicable
NCT07604155Enrolling By Invitation
Not Applicable
Maxillary Sinus Augmentation Using CAD/CAM Allogenic Bone Blocks Versus Particul...Tanta University
NCT07604870
Krill Oil and Metformin in Women With PCOS and Metabolically Unhealthy ObesityFirat UniversityCompletedPhase 2
NCT07604870Completed
Phase 2
Krill Oil and Metformin in Women With PCOS and Metabolically Unhealthy ObesityFirat University
Result Breakdown
Not yet recruiting10 (50%)
Recruiting4 (20%)
Completed4 (20%)
Active, not recruiting1 (5%)
Enrolling by invitation1 (5%)
not_applicable10 (50%)
Not Specified4 (20%)
Phase 12 (10%)
Phase 22 (10%)
Early Phase 11 (5%)
Phase 31 (5%)